DocuSign, Inc. (NASDAQ:DOCU) to Post FY2027 Earnings of $0.83 Per Share, Zacks Research Forecasts

DocuSign, Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research issued their FY2027 EPS estimates for shares of DocuSign in a research report issued on Thursday, March 28th. Zacks Research analyst R. Department anticipates that the company will post earnings per share of $0.83 for the year. The consensus estimate for DocuSign’s current full-year earnings is $0.81 per share.

A number of other equities analysts have also recently commented on DOCU. TheStreet raised shares of DocuSign from a “d+” rating to a “c-” rating in a research note on Tuesday, December 19th. Morgan Stanley raised shares of DocuSign from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. Wells Fargo & Company dropped their price target on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research note on Monday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $50.00 price target on shares of DocuSign in a research note on Friday, January 12th. Finally, Piper Sandler dropped their price target on shares of DocuSign from $57.00 to $50.00 and set a “neutral” rating for the company in a research note on Friday, December 8th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, DocuSign currently has an average rating of “Hold” and an average target price of $58.33.

DocuSign Stock Up 0.5 %

Shares of NASDAQ:DOCU opened at $59.55 on Friday. DocuSign has a 52 week low of $38.11 and a 52 week high of $64.76. The stock has a market capitalization of $12.23 billion, a P/E ratio of 165.42, a PEG ratio of 5.52 and a beta of 0.87. The firm has a fifty day simple moving average of $55.92 and a two-hundred day simple moving average of $50.35.

Insider Buying and Selling at DocuSign

In other DocuSign news, insider Stephen Shute sold 15,109 shares of the business’s stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the sale, the insider now directly owns 8,959 shares of the company’s stock, valued at approximately $510,842.18. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Allan C. Thygesen sold 7,420 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $58.19, for a total value of $431,769.80. Following the completion of the sale, the chief executive officer now owns 119,447 shares in the company, valued at approximately $6,950,620.93. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Stephen Shute sold 15,109 shares of the business’s stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $57.02, for a total transaction of $861,515.18. Following the completion of the sale, the insider now owns 8,959 shares of the company’s stock, valued at approximately $510,842.18. The disclosure for this sale can be found here. Insiders sold a total of 45,491 shares of company stock valued at $2,604,469 in the last three months. Company insiders own 17.80% of the company’s stock.

Institutional Investors Weigh In On DocuSign

Large investors have recently modified their holdings of the business. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its holdings in shares of DocuSign by 440.0% in the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock valued at $28,000 after purchasing an additional 220 shares in the last quarter. Capital Analysts LLC raised its holdings in shares of DocuSign by 781.7% in the 4th quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after purchasing an additional 469 shares in the last quarter. BluePath Capital Management LLC bought a new stake in shares of DocuSign in the 3rd quarter valued at about $32,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of DocuSign in the 4th quarter valued at about $32,000. Finally, Virtus Fund Advisers LLC bought a new position in shares of DocuSign during the 4th quarter worth approximately $33,000. Institutional investors own 77.64% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.